Edgewise Therapeutics
EWTX----
Edgewise Therapeutics (EWTX)
Edgewise Therapeutics, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapies for the treatment of muscle disorders. Its lead prod...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
- 52wk Low
- --
- Float Mkt Cap
- --
- Market Cap
- --
- P/ETTM
- --
- P/EDynamic
- --
- P/EStatic
- --
- EPSTTM
- --
- EPSDynamic
- --
- EPSStatic
- --
- BVPS
- --
- P/B
- --
- Circulating Supply
- --
- Dividend YieldTTM
- --
- DividendTTM
- --
- Shares
- --
- Min lot size
- --
- Currency
- --
Edgewise Therapeutics Analyst Rating
View moreForecast & Rating
Oct 30, 2026Price forecast
$54.0038.82%
Forecast & RatingStrong buy
13analysts
- Strong buy69.23%
- Buy23.08%
- Hold7.69%
- Sell0.00%
- Strong sell0.00%
News
- Wallstreetcn ·
The Nasdaq Biotechnology Index closed up over 1.1%
- Wallstreetcn ·
The Nasdaq Biotechnology Index rose by more than 2.9%. Among them, Theravance BioPharma rose by 22.55%, Edgewise Therapeutics rose by 17.51%, uniQure NV rose by 17.48%, and Autolus Therapeutics rose by 14.39%. In contrast, Pyxis Oncology fell by 4.19%, Humacyte fell by 5.19%, and Olema fell by 5.86%
